James N. Deangelo

Allergy and Immunology

180 Fort Couch Rd Ste 375
Pittsburgh, PA 15241

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens.

Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens.

Journal: Journal of clinical immunology

Published: March 16, 2023

Showing 1-1 of 1

Last Updated: 09/26/2026